- Home
- UBX vs REBN Comparison
UBX vs REBN Comparison
Compare UBX & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- REBN
- Stock Information
- Founded
- UBX 2009
- REBN 2015
- Country
- UBX United States
- REBN United States
- Employees
- UBX N/A
- REBN N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- REBN Restaurants
- Sector
- UBX Health Care
- REBN Consumer Discretionary
- Exchange
- UBX Nasdaq
- REBN Nasdaq
- Market Cap
- UBX 20.4M
- REBN 16.5M
- IPO Year
- UBX 2018
- REBN 2022
- Fundamental
- Price
- UBX $1.06
- REBN $3.83
- Analyst Decision
- UBX Strong Buy
- REBN
- Analyst Count
- UBX 3
- REBN 0
- Target Price
- UBX $5.33
- REBN N/A
- AVG Volume (30 Days)
- UBX 227.8K
- REBN 118.1K
- Earning Date
- UBX 05-13-2025
- REBN 04-15-2025
- Dividend Yield
- UBX N/A
- REBN N/A
- EPS Growth
- UBX N/A
- REBN N/A
- EPS
- UBX N/A
- REBN N/A
- Revenue
- UBX N/A
- REBN $5,928,533.00
- Revenue This Year
- UBX N/A
- REBN $185.18
- Revenue Next Year
- UBX N/A
- REBN $64.55
- P/E Ratio
- UBX N/A
- REBN N/A
- Revenue Growth
- UBX N/A
- REBN 9.70
- 52 Week Low
- UBX $0.94
- REBN $1.03
- 52 Week High
- UBX $3.10
- REBN $8.80
- Technical
- Relative Strength Index (RSI)
- UBX 31.85
- REBN 44.84
- Support Level
- UBX $1.16
- REBN $3.54
- Resistance Level
- UBX $1.22
- REBN $4.18
- Average True Range (ATR)
- UBX 0.13
- REBN 0.38
- MACD
- UBX -0.06
- REBN -0.09
- Stochastic Oscillator
- UBX 12.22
- REBN 19.15
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.